Quantifying fetal alcohol exposure by meconium fatty acid ethyl esters (FAEE); association with adverse fetal outcomes and population estimates of fetal alcohol exposure

References

• Abel EL. 1995. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 17(4):437–443.
   PubMed Web of Science ®Google Scholar
• Abernethy C, McCall KE, Cooper G, Favretto D, Vaiano F, Bertol E, Mactier H. 2018. Determining the pattern and prevalence of alcohol consumption in pregnancy by measuring biomarkers in meconium. Arch Dis Child Fetal Neonatal Ed. 103(3):F216–F220.
   PubMed Web of Science ®Google Scholar
• Bakdash A, Burger P, Goecke TW, Fasching PA, Reulbach U, Bleich S, Hastedt M, Rothe M, Beckmann MW, Pragst F, et al. 2010. Quantification of fatty acid ethyl estersand ethyl glucuronide in meconium of newborms for detection of alcohol abuse in a maternal evaluation study. Anal Bioanal Chem. 396(7):2469–2477.
   PubMed Web of Science ®Google Scholar
• Bakhireva LN, Kane MA, Bearer CF, Bautista A, Jones JW, Garrison L, Begay M-G, Ozechowski T, Lewis J. 2019. Prenatal alcohol exposure prevalence as measured by direct ethanol metabolites in meconium of Native American tribe of the southwest. Birth Defects Res. 111(2):53–61.
   PubMedGoogle Scholar
• Bearer CF, Gould S, Emerson R, Kinnunen P, Cook CS. 1992. Fetal alcohol syndrome and fatty acid ethyl esters. Pediatr Res. 31(5):492–495.
   PubMed Web of Science ®Google Scholar
• Bearer CF, Jacobson JL, Jacobson SW, Barr D, Croxford J, Molteno CD, Viljoen DL, Marais AS, Chiodo LM, Cwik AS. 2003. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 143(4):463–469.
   PubMed Web of Science ®Google Scholar
• Brien JF, Chan D, Green CR, Iqbal U, Gareri J, Kobus SM, McLaughlin BE, Klein J, Rao C, Reynolds JN, et al. 2006. Chronic prenatal ethanol exposure and increased concentration of fatty acid ethyl esters in meconium of term fetal guinea pig. Ther Drug Monit. 28:345–350.
   PubMed Web of Science ®Google Scholar
• Bearer CF, Lee S, Salvator AE, Minnes S, Swick A, Yamashita T, Singer LT. 1999. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 23(3):487–493.
   PubMed Web of Science ®Google Scholar
• Bryanton J, Gareri J, Boswall D, McCarthy MJ, Fraser B, Walsh D, Freeman B, Koren G, Bigsby K. 2014. Incidence of prenatal alcohol exposure in Prince Edward Island: a population-based descriptive study. CMAJ Open. 2(2):E121–E126.
   PubMedGoogle Scholar
• Calarco KE, Mattson SN, Robertson B, Riley EP. 2003. Heavy prenatal alcohol exposure or ADHD? errors make the difference. J Int Neuropsychol Soc. 9:152.
   Google Scholar
• Caprara DL, Brien JF, Iqbal U, Reynolds JN, Klein J, Koren G. 2005. A Guinea pig model for the identification of in utero alcohol exposure using fatty acid ethyl esters in neonatal hair. Pediatr Res. 58(6):1158–1163.
   PubMed Web of Science ®Google Scholar
• Caprara DL, Klein J, Koren G. 2005. Baseline measures of fatty acid ethyl esters in hair of neonates born to abstaining or mild social drinking mothers. Ther Drug Monit. 27(6):811–815.
   PubMed Web of Science ®Google Scholar
• Caprara DL, Klein J, Koren G. 2006. Diagnosis of fetal alcohol spectrum disorder (FASD): fatty acid ethyl esters and neonatal hair analysis. Ann Ist Super Sanita. 42(1):39–45.
   PubMedGoogle Scholar
• Chan D, Bar-Oz B, Pellerin B, Paciorek C, Klein J, Kapur B, Farine D, Koren G. 2003. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 25(3):271–278.
   PubMed Web of Science ®Google Scholar
• Chan D, Knie B, Boskovic R, Koren G. 2004. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. J Pharmacol Exp Ther. 310(1):75–82.
   PubMed Web of Science ®Google Scholar
• Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N, Public Health Agency of Canada's National Advisory Committee on Fetal Alcohol Spectrum Disorder. 2005. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 172(5_suppl):S1–S21.
   PubMed Web of Science ®Google Scholar
• Delano K, Koren G, Zack M, Kapur B. 2019. Prevalence of fetal alcohol exposure by analysis of meconium fatty acid ethyl esters: a national Canadian study. Sci Rep. 9(1):2298.
   PubMedGoogle Scholar
• Denys K, Rasmussen C, Henneveld D. 2011. The effectiveness of a community-based intervention for parents with FASD. Community Ment Health J. 47(2):209–219.
   PubMed Web of Science ®Google Scholar
• Derauf C, Katz AR, Easa D. 2003. Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine. Am J Epidemiol. 158(7):705–709.
   PubMed Web of Science ®Google Scholar
• Doyle KM, Bird DA, Al-Salihi S, Hallaq Y, Cluette-Brown JE, Goss KA, Laposata M. 1994. Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res. 35(3):428–437.
   PubMed Web of Science ®Google Scholar
• Doyle KM, Cluette-Brown JE, Dube DM, et al. 1996. Fatty acid ethyl esters in the blood as biomarkers for ethanol intake. JAMA. 976:1152–1157.
   Google Scholar
• Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN. 2007. Evaluation of psycho- pathological conditions in children with heavy prenatal alcohol exposure. Pediatrics. 119(3):e733–41.
   PubMed Web of Science ®Google Scholar
• Garcia-Algar O, Kulaga V, Gareri J, Koren G, Vall O, Zuccaro P, Pacifici R, Pichini S. 2008. Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Ther Drug Monit. 30(2):249–254.
   PubMed Web of Science ®Google Scholar
• Gareri J, Brien J, Reynolds J, Koren G. 2009. Potential role of the placenta in fetal alcohol spectrum disorder. Paediatr Drugs. 11(1):26–29.
   PubMedGoogle Scholar
• Gareri JN. 2015. Translational studies of fatty acid ethyl esters (FAEE)meconium and hair as biomarkers of prenatal ethanol exposure risk. PhD thesis. University of Toronto. Dept. of Pharmaceutical Sciences.
   Google Scholar
• Goh YI, Hutson JR, Lum L, Roukema H, Gareri J, Lynn H, Koren G. 2010. Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit. Alcohol. 44(7-8):629–634.
   PubMed Web of Science ®Google Scholar
• Gourley GR, Kreamer B, Arend R. 1990. Excremental studies in human neonates. Identification of zinc coproporphyrin as a marker for meconium. Gastroenterology. 99:1705–1709.
   PubMed Web of Science ®Google Scholar
• Himes SK, Concheiro M, Scheidweiler KB, Huestis MA. 2014. Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Anal Bioanal Chem. 406(7):1945–1955.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (U.S.). 1996. Fetal alcohol syndrome: diagnosis, epidemiology, prevention and treatment. In: Stratton K, Howe C, Battaglia F, editors. Fetal alcohol syndrome. Washington, DC: National Academy Press.
   Google Scholar
• Jacobson SW, Bearer CF, Jacobson JL, et al. 2006. Meconium fatty acid ethyl esters (FAEEs) as predictors of severity of fetal alcohol spectrum disorder. Alcohol Clin Exp Res. 30(s1):175A.
   Google Scholar
• Jones AW. 2010. Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework. Forensic Sci Int. 200(1-3):1–20.
   PubMed Web of Science ®Google Scholar
• Jones KL, Smith DW. 1973. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 302(7836):999–1001.
   PubMed Web of Science ®Google Scholar
• Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. 2008. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther. 84(5):604–612.
   PubMed Web of Science ®Google Scholar
• Klein J, Chan D, Koren G. 2002. Neonatal hair analysis as a biomarker for in utero alcohol exposure. N Engl J Med. 347(25):2086.
   PubMed Web of Science ®Google Scholar
• Klein J, Karaskov T, Koren G. 1999. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther Drug Monit. 21(6):644–646.
   PubMed Web of Science ®Google Scholar
• Kotch LE, Sulik KK. 1992. Experimental fetal alcohol syndrome: proposed pathogenic basis for a variety of associated facial and brain anomalies. Am J Med Genet. 44(2):168–176.
   PubMed Web of Science ®Google Scholar
• Lange LG, Bergmann SR, Sobel BE. 1981. Identification of fatty acid ethyl esters as products of rabbit myocardial ethanol metabolism. J Biol Chem. 256(24):12968–12973.
   PubMed Web of Science ®Google Scholar
• Lange S, Shield K, Koren G, Rehm J, Popova S. 2014. A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth. 14:127.
   PubMed Web of Science ®Google Scholar
• Littner Y, Cudd TA, O'Riordan MA, Cwik A, Bearer CF. 2008. Elevated fatty acid ethyl esters in meconium of sheep fetuses exposed in utero to ethanol-a new animal model. Pediatr Res. 63(2):164–168.
   PubMed Web of Science ®Google Scholar
• MacPherson P, Chudley AE. 2011. FASD: Screening and estimating prevalence in an adult federal correctional population. Presented at Fetal Alcohol Canadian Expertise Research Roundtable, Charlottetwon. PEI September 13, 2011.
   Google Scholar
• Matlow JN, Lubetsky A, Aleksa K, Berger H, Koren G. 2013. The transfer of ethyl glucuronide across the dually perfused human placenta. Placenta. 34(4):369–373.
   PubMed Web of Science ®Google Scholar
• Mattson SN, Lang AR, Calarco KE. 2002. Attentional focus and attentional shift in children with heavy prenatal alcohol exposure. J Int Neuropsychol Soc. 8:295.
   Google Scholar
• May PA, Blankenship J, Marais AS, Gossage JP, Kalberg WO, Joubert B, Cloete M, Barnard R, De Vries M, Hasken J, et al. 2013. Maternal alcohol consumption producing fetal alcohol spectrum disorders (FASD): quantity, frequency, and timing of drinking. Drug Alcohol Depend. 133(2):502–512.
   PubMed Web of Science ®Google Scholar
• Miller V, Holzel A. 1974. Growth and development of endodermal structures. In: Dobbing J, editor. Scientific foundations in pediatrics. Philadelphia (USA): WB Saunders. p. 281–296.
   Google Scholar
• Moller M, Gareri J, Koren G. 2010. A review of substance abuse monitoring in a social services context: a primer for child protection workers. Can J Clin Pharmacol. 17(1):e177–e193.
   PubMedGoogle Scholar
• Noland JS, Singer LT, Arendt RE, Minnes S, Short EJ, Bearer CF. 2003. Executive functioning in preschool-age children prenatally exposed to alcohol, cocaine, and marijuana. Alcohol Clin Exp Res. 27(4):647–656.
   PubMed Web of Science ®Google Scholar
• Noland JS, Singer LT, Mehta SK, Super DM. 2003. Prenatal cocaine/polydrug exposure and infant performance on an executive functioning task. Dev Neuropsychol. 24(1):499–517.
   PubMed Web of Science ®Google Scholar
• Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Lester Kirchner H, Bearer C. 2005. Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol. 27(3):429–438.
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Kennedy D, Wasson C, Gladstone J, Fried S, Koren G. 2004. Binge alcohol consumption by non-alcohol-dependent women during pregnancy affects child behaviour, but not general intellectual functioning; a prospective controlled study. Arch Womens Ment Health. 7(3):173–181.
   PubMedGoogle Scholar
• Ostrea EMJ, Brady MJ, Parks PM, Asensio DC, Naluz A. 1989. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr. 115(3):474–477.
   PubMed Web of Science ®Google Scholar
• Ostrea EMJ, Romero A, Knapp DK, Ostrea AR, Lucena JE, Utarnachitt RB. 1994. Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: clinical implications. JPediatr. 124(3):477–479.
   PubMed Web of Science ®Google Scholar
• Patrenko CL, Tahir N, Mahoney EC, Chin NP. 2014. A qualitative assessment of program characteristics for preventing secondary conditions in individuals with fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol. 21(2):e246–59.
   PubMedGoogle Scholar
• Peterson J, Kirchner HL, Xue W, Minnes S, Singer LT, Bearer CF. 2008. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J Pediatr. 152(6):788–792.
   PubMed Web of Science ®Google Scholar
• Pragst F, Auwaerter V, Sporkert F, Spiegel K. 2001. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci Int. 121(1-2):76–88.
   PubMed Web of Science ®Google Scholar
• Riley EP, McGee CL. 2005. Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med (Maywood). 230(6):357–365.
   PubMed Web of Science ®Google Scholar
• Russell M, Martier SS, Sokol RJ, Mudar P, Jacobson S, Jacobson J. 1996. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 86(10):1435–1439.
   PubMed Web of Science ®Google Scholar
• Sampson PD, Streissguth AP, Bookstein FL, Little RE, Clarren SK, Dehaene P, Hanson JW, Graham JM. Jr. 1997. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 56(5):317–326.
   PubMedGoogle Scholar
• Sarkar M, Burnett M, Carrière S, Cox LV, Dell CA, Gammon H, Geller B, Koren G, Lee L, Midmer D, Fetal Alcohol Spectrum Disorder Advisory Workgroup, et al. 2009. Screening and recording of alcohol use among women of child-bearing age and pregnant women. Can J Clin Pharmacol. 16(1):e242–e263.
   PubMedGoogle Scholar
• Shor S, Nulman I, Kulaga V, Koren G. 2010. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population. Alcohol. 44(7-8):623–627.
   PubMed Web of Science ®Google Scholar
• Silvestre MA, Lucena JE, Roxas RJ, Evangelista ES, Ostrea E. 1997. Effects of timing, dosage, and duration of morphine intake during pregnancy on the amount of morphine in meconium in a rat model. Biol Neonate. 72(2):112–117.
   PubMedGoogle Scholar
• Taylor P, Bailey D, Green SR, McCully C. 2012. Substance abuse during pregnancy: guidelines for screening. Seattle, USA: Washington State Department of Health.
   Google Scholar
• Verma A, Dhanireddy R. 1993. Time of first stool in extremely low birth weight (< or = 1000 grams) infants. J Pediatr. 122(4):626–629.
   PubMed Web of Science ®Google Scholar
• Yang JY, Kwak HS, Han JY, Choi JS, Ahn HK, Oh YJ, Velázquez-Armenta EY, Nava-Ocampo AA. 2015. Linear versus non-linear dose-response relationship between prenatal alcohol exposure and meconium concentration of nine different fatty acid ethyl esters. Dose Response. DOI:10.2203/dose-response.14-056_Yang
   PubMed Web of Science ®Google Scholar
• Zelner I, Hutson JR, Kapur BM, Feig DS, Koren G. 2012. False-positive meconium test results for fatty acid ethyl esters secondary to delayed sample collection. Alcohol Clin Exp Res. 36(9):1497–1506.
   PubMed Web of Science ®Google Scholar
• Zelner I, Kenna K, Brien JF, Bocking A, Harding R, Walker D, Koren G. 2013. Meconium fatty acid ethyl esters as biomarkers of late gestational ethanol exposure and indicator of ethanol-induced multi-organ injury in fetal sheep. PLoS One. 8(3):e59168.
   PubMed Web of Science ®Google Scholar
• Zelner I, Shor S, Lynn H, Roukema H, Lum L, Eisinga K, Koren G. 2012. Clinical use of meconium fatty acid ethyl esters for identifying children at risk for alcohol-related disabilities: the first reported case. J Popul Ther Clin Pharmacol. 19(1):e26–e31.
   PubMedGoogle Scholar